about
Back to the future: ribonuclease ATargeting Lysine Deacetylases (KDACs) in ParasitesA crowdsourcing evaluation of the NIH chemical probes3D model for TM region of the AT-1 receptor in complex with angiotensin II independently validated by site-directed mutagenesis data.Impact of azaproline on amide cis-trans isomerism: conformational analyses and NMR studies of model peptides including TRH analogues.A virtual library of constrained cyclic tetrapeptides that mimics all four side-chain orientations for over half the reverse turns in the protein data bank.Impact of azaproline on Peptide conformation.The development and application of a novel safety-catch linker for BOC-based assembly of libraries of cyclic peptides.Antimycobacterial pyrroles: synthesis, anti-Mycobacterium tuberculosis activity and QSAR studies.Peptide-bond modification for metal coordination: peptides containing two hydroxamate groups.Impact of cis-proline analogs on peptide conformation.Modulating G-protein coupled receptor/G-protein signal transduction by small molecules suggested by virtual screening.Targeting the dimerization of epidermal growth factor receptors with small-molecule inhibitors.Motion of carboxyl terminus of Galpha is restricted upon G protein activation. A solution NMR study using semisynthetic Galpha subunits.An Automated Strategy for Binding-Pose Selection and Docking Assessment in Structure-Based Drug Design.Do benzodiazepines mimic reverse-turn structures?Solid-phase synthesis: a paradigm shift.High-resolution crystal structures of protein helices reconciled with three-centered hydrogen bonds and multipole electrostatics.Inhibition of bacterial virulence: drug-like molecules targeting the Salmonella enterica PhoP response regulator.Expressed protein ligation to study protein interactions: semi-synthesis of the G-protein alpha subunit.Privileged scaffolds targeting reverse-turn and helix recognition.A second look at mini-protein stability: analysis of FSD-1 using circular dichroism, differential scanning calorimetry, and simulations.Computer-aided molecular modeling of a D2-agonist dopamine pharmacophore.Therapeutic approaches to human immunodeficiency virus: structural studies on G-protein-coupled receptors.PHOENIX: a scoring function for affinity prediction derived using high-resolution crystal structures and calorimetry measurementsHIV-1 protease inhibitors: ketomethylene isosteres with unusually high affinity compared with hydroxyethylene isostere analogs.Molecular dynamics of β-hairpin models of epigenetic recognition motifs.Molecular mechanisms of constitutive activity: mutations at position 111 of the angiotensin AT1 receptor.Electron paramagnetic resonance studies of functionally active, nitroxide spin-labeled peptide analogues of the C-terminus of a G-protein alpha subunitC-terminally shortened alamethicin on templates: influence of the linkers on conductances.Simplified modeling approach suggests structural mechanisms for constitutive activation of the C5a receptor.Difference between restoring and predicting 3D structures of the loops in G-protein-coupled receptors by molecular modeling.SKATE: a docking program that decouples systematic sampling from scoring.Modeling the possible conformations of the extracellular loops in G-protein-coupled receptors.Helix stability of oligoglycine, oligoalanine, and oligo-β-alanine dodecamers reflected by hydrogen-bond persistence.A unique geometry of the active site of angiotensin-converting enzyme consistent with structure-activity studies.The veil of commercialism.Design, synthesis and QSAR studies on N-aryl heteroarylisopropanolamines, a new class of non-peptidic HIV-1 protease inhibitors.Metal complexes of chiral pentaazacrowns as conformational templates for beta-turn recognition.Partial sequence of rat prothrombin and the activity of two related pentapeptides as substrates for the vitamin K-dependent carboxylase system.
P50
Q28248769-E91AE9C0-59B5-4A9F-ABF9-9ED96428C17DQ28548415-FB007369-E857-42DF-ACBE-1FC7DBA93D60Q28842738-879446C8-FC19-40AC-A1FD-2B2B3F819CBDQ30659430-A57D5C0D-87CC-4252-9BDB-0ABEE0EB4949Q30764532-90F7EABE-5447-499D-8F37-DAD4D21C573EQ30847753-15A70C5D-FE14-4CB7-8F3E-64F9373E2A3DQ30978895-69406564-7BFC-48CE-9CB1-74D24CD7B0FAQ31029069-7C140CFA-7A1E-4DE4-8B3F-F98B90825205Q31407411-BDD040CC-05F9-44F4-87C3-97A5E60EBF4EQ33193503-E55F6B60-1C25-42D4-88E9-AC38823C17CDQ33229622-6AEBB36C-4E2E-490E-AB3A-E05A65A88A6EQ33360557-1487ED97-8B63-41A9-80AB-C1098BF989A5Q33574021-A7C45B84-6326-4303-B589-8F42BA8A2643Q34313218-05B3901E-0428-411B-B1E3-D8917138662FQ34505706-B1525BBF-2112-47D4-90F6-A98E390B9678Q34566045-3F721AA7-7548-4C3B-B959-77FB9902B0ADQ35557087-5E46573A-9DE1-4A62-A5FF-63032072108FQ35610069-837A8EBC-16A7-4EF7-835B-720E507B0B6BQ36242811-1AF204B2-EA21-4C03-A49F-B182E0280780Q36321222-637D5C2D-F0FF-4531-8921-35E57CFF2648Q37030888-BB0BD798-FEAA-412E-9AE6-CA0E7E4ABFB5Q37418891-61FAAD29-BC1E-4AA1-A17B-6D0200CAB7DBQ41448933-8FAC0288-9DF7-4251-BDA2-1B113C590ECBQ41735637-6C8B0234-AFBD-4130-AA36-DB5DA3727F35Q42182002-777AD294-F02D-49A9-83B8-88959D9F4A8FQ42278567-DE05E4D3-58B7-4A66-82E7-4152E32A52F3Q42399228-B9892417-93EA-436F-929C-47077B768BF3Q42485190-19956E16-C1F3-4713-B6A4-4F6900411999Q42543408-E6855D1B-AA74-4DD7-8A9F-2623D054F07FQ42607787-5014D428-3B23-4736-A806-AC5614C4E1F8Q42712396-C6759E25-8F74-4B39-81FD-9B6B301CB08DQ42846026-70980203-2521-4E6F-9CE8-9A2CC43196B9Q42925398-775CE6E8-8919-4B87-B696-EA8C6D6C03EDQ42951624-548C3DE1-41DB-4CB9-AC19-22284D70E564Q42957108-6A91480E-24F2-4340-AFE1-1EE8EF3B05FCQ43773521-D23CA9E2-0711-4668-964D-68B0BAE6B11BQ43993646-8E90130F-2E0D-4A1B-938A-784358BB4247Q44022775-769BF30B-845B-4B03-A6D8-143931CC56E4Q44325908-148E85DF-4B24-4307-8C66-62E02E5FE21DQ44412308-929E5CF0-CCCD-48CF-B35A-F779C982C9E1
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Garland R. Marshall
@ast
Garland R. Marshall
@en
Garland R. Marshall
@es
Garland R. Marshall
@nl
Garland R. Marshall
@sl
type
label
Garland R. Marshall
@ast
Garland R. Marshall
@en
Garland R. Marshall
@es
Garland R. Marshall
@nl
Garland R. Marshall
@sl
prefLabel
Garland R. Marshall
@ast
Garland R. Marshall
@en
Garland R. Marshall
@es
Garland R. Marshall
@nl
Garland R. Marshall
@sl
P106
P1153
7402287380
P2456
P31
P496
0000-0002-3098-0332